Beacon Investment Advisory Services Inc. bought a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH) during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 1,169 shares of the healthcare conglomerate’s stock, valued at approximately $217,000.

Several other institutional investors also recently made changes to their positions in the company. Patriot Financial Group Insurance Agency LLC grew its holdings in shares of UnitedHealth Group by 1,722.9% during the first quarter. Patriot Financial Group Insurance Agency LLC now owns 638 shares of the healthcare conglomerate’s stock valued at $106,000 after buying an additional 603 shares in the last quarter. Kings Point Capital Management grew its holdings in shares of UnitedHealth Group by 27.9% during the first quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock valued at $113,000 after buying an additional 150 shares in the last quarter. Founders Capital Management purchased a new position in shares of UnitedHealth Group during the first quarter valued at $135,000. Parkside Financial Bank & Trust grew its holdings in shares of UnitedHealth Group by 1.4% during the first quarter. Parkside Financial Bank & Trust now owns 854 shares of the healthcare conglomerate’s stock valued at $140,000 after buying an additional 12 shares in the last quarter. Finally, Hanson McClain Inc. grew its holdings in shares of UnitedHealth Group by 1.7% during the first quarter. Hanson McClain Inc. now owns 895 shares of the healthcare conglomerate’s stock valued at $147,000 after buying an additional 15 shares in the last quarter. 86.11% of the stock is currently owned by institutional investors.

A number of research analysts have recently weighed in on UNH shares. Cantor Fitzgerald reiterated an “overweight” rating and set a $208.00 price target on shares of UnitedHealth Group in a report on Friday, July 21st. ValuEngine upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Friday, September 1st. Zacks Investment Research downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Monday, July 31st. Oppenheimer Holdings, Inc. reiterated an “outperform” rating and set a $205.00 price target (up previously from $203.00) on shares of UnitedHealth Group in a report on Friday, July 21st. Finally, BidaskClub downgraded UnitedHealth Group from a “strong-buy” rating to a “buy” rating in a report on Wednesday, July 19th. Three analysts have rated the stock with a hold rating and twenty-four have given a buy rating to the company’s stock. UnitedHealth Group currently has an average rating of “Buy” and an average price target of $215.27.

In related news, Director Gail R. Wilensky sold 5,600 shares of UnitedHealth Group stock in a transaction dated Tuesday, September 5th. The stock was sold at an average price of $199.49, for a total transaction of $1,117,144.00. Following the completion of the transaction, the director now owns 60,834 shares in the company, valued at $12,135,774.66. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Larry C. Renfro sold 50,574 shares of UnitedHealth Group stock in a transaction dated Friday, September 15th. The stock was sold at an average price of $198.11, for a total value of $10,019,215.14. Following the transaction, the insider now owns 195,625 shares of the company’s stock, valued at approximately $38,755,268.75. The disclosure for this sale can be found here. Insiders have sold 76,174 shares of company stock valued at $14,981,909 in the last quarter. 0.89% of the stock is currently owned by corporate insiders.

ILLEGAL ACTIVITY WARNING: This news story was first reported by Watch List News and is owned by of Watch List News. If you are reading this news story on another website, it was stolen and reposted in violation of international trademark & copyright laws. The original version of this news story can be read at https://www.watchlistnews.com/beacon-investment-advisory-services-inc-takes-217000-position-in-unitedhealth-group-incorporated-unh/1642471.html.

UnitedHealth Group Incorporated (NYSE:UNH) opened at 203.25 on Friday. The firm has a market cap of $201.01 billion, a PE ratio of 23.08 and a beta of 0.63. The company’s 50 day moving average price is $197.17 and its 200 day moving average price is $185.63. UnitedHealth Group Incorporated has a 52-week low of $133.03 and a 52-week high of $207.80.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 EPS for the quarter, topping analysts’ consensus estimates of $2.57 by $0.09. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The business had revenue of $50.32 billion during the quarter, compared to analysts’ expectations of $50.38 billion. During the same quarter last year, the company posted $2.17 earnings per share. UnitedHealth Group’s quarterly revenue was up 8.7% on a year-over-year basis. Analysts predict that UnitedHealth Group Incorporated will post $9.91 earnings per share for the current fiscal year.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.